- Home
- MIST vs EAD Comparison
MIST vs EAD Comparison
Compare MIST & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.06
Company Overview
Basic Information| Metric | MIST | EAD |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.9M | 377.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MIST | EAD |
|---|---|---|
| Price | $1.06 | $6.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 294.6K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $6.24 |
| 52 Week High | $3.06 | $7.15 |
Technical Indicators
Market Signals| Indicator | MIST | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 44.42 |
| Support Level | $1.01 | $6.24 |
| Resistance Level | $1.42 | $6.45 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 9.26 | 12.50 |
Price Performance
Historical Comparison MIST
EAD
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. The Fund seeks a high level of current income. Capital appreciation is a secondary objective. The fund has single operating segment.